Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.






Home » Drug Information » FDA-Approved Drugs » 1998
Medical Areas: Oncology

View By: Year Company Therapeutic Areas Drug Names 

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Actiq

Company: Anesta Corporation
Approval Status: Approved November 1998
Treatment Area: Oncology

General Information

Actiq is used for the management of cancer pain in patients with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

Actiq is used to relieve the flares, called breakthrough cancer pain, that your regular prescribed pain medication does not control.

Actiq should not be used for:

  • Short-term pain, e.g. pain from injuries or surgery
  • Pain that is already being treated with a prescription opioid (narcotic) pain medicine every day on a regular schedule

Side Effects

Sleepiness, nausea or dizziness.

Mechanism of Action

Actiq contains a prescription opioid (narcotic) pain-relieving medicine called fentanyl. When you place it in your mouth it slowly dissolves, and the medicine is absorbed through the lining of your mouth. From there, it goes into your bloodstream.


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.